Local neutral networks help maintain inaccurately replicating ribozymes

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Szilágyi, András ^a,b   Kun, Ádám ^a,b   Szathmáry, Eörs ^a,b,c  

^a PARMENIDES FOUNDATION   (Germany)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c EÖTVÖS LORÁND UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

RIBOZYME; RNA DIRECTED RNA POLYMERASE; RNA;

ARTICLE; ARTIFICIAL NEURAL NETWORK; ARTIFICIAL SELECTION; CONTROLLED STUDY; ERROR THRESHOLD; GENE MUTATION; GENETIC PARAMETERS; MATHEMATICAL COMPUTING; MUTATIONAL ANALYSIS; RNA ANALYSIS; RNA REPLICATION; RNA SEQUENCE; RNA STABILITY; STRUCTURE ANALYSIS; BIOSYNTHESIS; COMPUTER SIMULATION; CONFORMATION; GENETIC DRIFT; GENETIC SELECTION; GENETICS; MUTATION; REPRODUCTIVE FITNESS; SEQUENCE ANALYSIS; THEORETICAL MODEL;

COMPUTER SIMULATION; GENETIC DRIFT; GENETIC FITNESS; MODELS, THEORETICAL; MUTATION; NUCLEIC ACID CONFORMATION; RNA; RNA, CATALYTIC; SELECTION, GENETIC; SEQUENCE ANALYSIS, RNA;

EID: 84907856514     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0109987     Document Type: Article

References (135)

1. Eigen M (1971) Selforganization of matter and the evolution of biological macromolecules. Naturwissenscaften 10: 465-523.
2. Maynard Smith J (1983) Models of evolution. Proceedings of the Royal Society of London B 219: 315-325.
3. Bernhardt H (2012) The RNA world hypothesis: The worst theory of the early evolution of life (except for all the others). Biology Direct 7: 23.
4. Joyce GF (2002) The antiquity of RNA-based evolution. Nature 418: 214-220.
5. Maurel M-C, Haenni AL (2005) The RNA world: Hypothesis, facts and experimental results. In: Barbier B, Gargaud M, Martin H, Reisse J, editors. Lectures in Astrobiology: Springer Verlag Ed. pp. 557-581.
6. Dworkin JP, Lazcano A, Miller SL (2003) The roads to and from the RNA world. Journal of Theoretical Biology 222: 127-134.
7. Cech TR, Atkins JF, Gesteland RF, editors (2005) The RNA World. 3rd edition ed: Cold Spring Harbor Laboratory Press. 768 p.
8. Yarus M (2011) Life from an RNA World: The Ancestor Within. Harvard, USA: Harvard University Press.
9. Chen X, Li N, Ellington AD (2007) Ribozyme catalysis of metabolism in the RNA World. Chemistry & Biodiversity 4: 633-655.
10. Chumachenko NV, Novikov Y, Yarus M (2009) Rapid and simple ribozymic aminoacylation using three conserved nucleotides. Journal of American Chemical Society 131: 5257-5263.
11. Santos M, Zintzaras E, Szathmáry E (2004) Recombination in primeval genomes: A step forward but still a long leap from maintaining a sizeable genome. Journal of Molecular Evolution 59: 507-519.
12. Rajamani S, Ichida JK, Antal T, Treco DA, Leu K, et al. (2010) Effect of stalling after mismatches on the error catastrophe in non enzymatic nucleic acid replication. Journal of the American Chemical Society 132: 5880-5885.
13. Lafontaine DA, Norman DG, Lilley DMJ (2002) The structure and active site of the Varkund satellite ribozyme. Biochemical Society Transactions 30: 1170- 1175.
14. Fedor M (2000) Structure and function of the hairpin ribozyme. Journal of Molecular Biology 297: 269-291.
15. Takeuchi N, Poorthuis PH, Hogeweg P (2005) Phenotypic error threshold; additivity and epistasis in RNA evolution. BMC Evolutionary Biology 5: 9.
16. Reidys C, Forst CV, Schuster P (2001) Replication and mutation on neutral networks. Bulletin of Mathematical Biology 63: 57-94.
17. Wochner A, Attwater J, Coulson A, Holliger P (2011) Ribozyme-catalyzed transcription of an active ribozyme. Science 332: 209-212.
18. Johnston WK, Unrau PJ, Lawrence MS, Glasen ME, Bartel DP (2001) RNA catalyzed RNA polymerization: Accurate and general RNA-templated primer extension. Science 292: 1319-1325.
19. Kun Á, Mauro S, Szathmáry E (2005) Real ribozymes suggest a relaxed error threshold. Nature Genetics 37: 1008-1011.
20. Flintoft L (2005) A relaxed approach to errors. Nature Reviews Genetics 6: 724-724.
21. van Nimwegen E, Crutchfield JP, Huynen MA (1999) Neutral evolution of mutational robustness. Proceedings of the National Academy of Sciences of the USA 96: 9716-9720.
22. Attwater J, Wochner A, Holliger P (2013) In-ice evolution of RNA polymerase ribozyme activity. Nature Chemistry 5: 1011-1018.
23. Eigen M, McCaskill JS, Schuster P (1988) Molecular quasi-species. Journal of Physical Chemistry 92.
24. Wilke CO, Ronnewinkel C, Martinetz T (2001) Dynamic fitness landscapes in molecular evolution. Physics Reports 349: 395-446.
25. Swetina J, Schuster P (1982) A model for polynucleotide replication. Biophysical Chemistry 46: 187-203.
26. Nowak M, Schuster P (1989) Error thresholds of replication in finite populations mutation frequencies and the onset of muller's ratchet. Journal of Theoretical Biology 137: 375-395.
27. Hofacker IL, Fontana W, Stadler PF, Bonhoeffer S, Tacker M, et al. (1994) Fast folding and comparison of RNA secondary structures. Monatchefte für Chemie 125: 167-188.
28. Grüner W, Giegerich R, Strothmann D, Reidys C, Weber J, et al. (1996) Analysis of RNA sequence structure maps by exhaustive enumeration II. Structures of neutral networks and shape space covering. Monatshefte für Chemie/Chemical Monthly 127: 375-389.
29. Schuster P, Stadler PF (1999) Nature and evolution of early replicons. In: Domingo E, Webster RG, Holland J, editors. Origin and Evolution of Viruses. New York: Academic Press. pp. 1-24.
30. Lee JF, Hesselberth JR, Meyers LA, Ellington AD (2004) Aptamer Database. Nucleic Acid Research 32: D95-D100.
31. Beaudry AA, Joyce GF (1992) Directed evolution of an RNA enzyme. Science 257: 635-641.
32. Bell SD, Denu JM, Dixon JE, Ellington AD (1998) RNA molecules that bind to and inhibit the active site of a tyrosine phosphatase. Journal of Biological Chemistry 273: 14309-14314.
33. Berens C, Thain A, Schroeder R (2001) A tetracycline-binding RNA aptamer. Bioorganic & Medicinal Chemistry 9: 2549-2556.
34. Bridonneau P, Chang Y-F, O'Connell D, Gill SC, Snyder DW, et al. (1998) High-affinity aptamers selectively inhibit human non pancreatic secretory phospholipase A2 (hnps-PLA2). Journal of Medicinal Chemistry 41: 778-786.
35. Brockstedt U, Uzarowska A, Montpetit A, Pfau W, Labuda D (2004) In vitro evolution of RNA aptamers recognizing carcinogenic aromatic amines. Biochemical and Biophysical Research Communications 313: 1004-1008.
36. Cerchia L, Ducongé F, Pestourie C, Boulay J, Aissouni Y, et al. (2005) Neutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinase. PLOS Biol 3: e123.
37. Chen C-hB, Chernis GA, Hoang VQ, Landgraf R (2003) Inhibition of heregulin signaling by an aptamer that preferentially binds to the oligomeric form of human epidermal growth factor receptor-3. Proceedings of the National Academy of Sciences 100: 9226-9231.
38. Coleman TM, Huang F (2002) RNA-catalyzed thioester synthesis. Chemistry & Biology 9: 1227-1236.
39. Conn MM, Prudent JR, Schultz PG (1996) Porphyrin metalation catalyzed by a small RNA molecule. Journal of the American Chemical Society 118: 7012- 7013.
40. Conrad R, Keranen LM, Ellington AD, Newton AC (1994) Isozyme-specific inhibition of protein kinase C by RNA aptamers. Journal of Biological Chemistry 269: 32051-32054.
41. Conrad R, Ellington AD (1996) Detecting immobilized protein kinase C isozymes with RNA aptamers. Analytical Biochemistry 242: 261-265.
42. Cox JC, Rudolph P, Ellington AD (1998) Automated RNA selection. Biotechnology Progress 14: 845-850.
43. Cox JC, Ellington AD (2001) Automated selection of anti-Protein aptamers. Bioorganic & Medicinal Chemistry 9: 2525-2531.
44. Daniels DA, Chen H, Hicke BJ, Swiderek KM, Gold L (2003) A tenascin-C aptamer identified by tumor cell SELEX: Systematic evolution of ligands by exponential enrichment. Proceedings of the National Academy of Sciences 100: 15416-15421.
45. Eulberg D, Buchner K, Maasch C, Klussmann S (2005) Development of an automated in vitro selection protocol to obtain RNA-based aptamers: identification of a biostable substance P antagonist. Nucleic Acids Research 33: e45.
46. Fukuda K, Vishnuvardhan D, Sekiya S, Hwang J, Kakiuchi N, et al. (2000) Isolation and characterization of RNA aptamers specific for the hepatitis C virus nonstructural protein 3 protease. European Journal of Biochemistry 267: 3685-3694.
47. Fusz S, Eisenführ A, Srivatsan SG, Heckel A, Famulok M (2005) A ribozyme for the aldol reaction. Chemistry & Biology 12: 941-950.
48. Gal SW, Amontov S, Urvil PT, Vishnuvardhan D, Nishikawa F, et al. (1998) Selection of a RNA aptamer that binds to human activated protein C and inhibits its protease function. European Journal of Biochemistry 252: 553-562.
49. Gebhardt K, Shokraei A, Babaie E, Lindqvist BH (2000) RNA aptamers to Sadenosylhomocysteine: Kinetic properties, divalent cation dependency, and comparison with anti-S-adenosylhomocysteine antibody. Biochemistry 39: 7255-7265.
50. Geiger A, Burgstaller P, von der Eltz H, Roeder A, Famulok M (1996) RNA aptamers that bind l-arginine with sub-micro molar dissociation constants and high enantioselectivity. Nucleic Acids Research 24: 1029-1036.
51. Gening LV, Klincheva SA, Reshetnjak A, Grollman AP, Miller H (2006) RNA aptamers selected against DNA polymerase b inhibit the polymerase activities of DNA polymerases b and k. Nucleic Acids Research 34: 2579-2586.
52. Hager AJ, Szostak JW (1997) Isolation of novel ribozymes that ligate AMP activated RNA substrates. Chemistry & Biology 4: 607-617.
53. Haller AA, Sarnow P (1997) In vitro selection of a 7-methyl-guanosine binding RNA that inhibits translation of capped mRNA molecules. Proceedings of the National Academy of Sciences 94: 8521-8526.
54. Hamm J, Huber J, Lührmann R (1997) Anti-idiotype RNA selected with an anti-nuclear export signal antibody is actively transported in oocytes and inhibits Rev- And cap-dependent RNA export. Proceedings of the National Academy of Sciences 94: 12839-12844.
55. Hartmann R, Nørby PL, Martensen PM, Jørgensen P, James MC, et al. (1998) Activation of 29-59 oligoadenylate synthetase by single-stranded and doublestranded RNA aptamers. Journal of Biological Chemistry 273: 3236-3246.
56. Hesselberth JR, Miller D, Robertus J, Ellington AD (2000) In vitro selection of RNA molecules that Inhibit the activity of ricin A-chain. Journal of Biological Chemistry 275: 4937-4942.
57. Hirao I, Harada Y, Nojima T, Osawa Y, Masaki H, et al. (2004) In vitro selection of RNA aptamers that bind to colicin E3 and structurally resemble the decoding site of 16S ribosomal RNA. Biochemistry 43: 3214-3221.
58. Hirao I, Spingola M, Peabody D, Ellington A (1998) The limits of specificity: An experimental analysis with RNA aptamers to MS2 coat protein variants. Molecular Diversity 4: 75-89.
59. Hornung V, Hofmann H-P, Sprinzl M (1998) In vitro selected RNA molecules that bind to elongation factor Tu. Biochemistry 37: 7260-7267.
60. Huang F, Bugg CW, Yarus M (2000) RNA-catalyzed CoA, NAD, and FAD synthesis from phosphopantetheine, NMN, and FMN. Biochemistry 39: 15548-15555.
61. Huang F, Yarus M (1997) 59-RNA self-capping from guanosine diphosphate. Biochemistry 36: 6557-6563.
62. Li N, Huang F (2005) Ribozyme-catalyzed aminoacylation from CoA thioesters. Biochemistry 44: 4582-4590.
63. Hwang B, Lee S-W (2002) Improvement of RNA aptamer activity against myasthenic autoantibodies by extended sequence selection. Biochemical and Biophysical Research Communications 290: 656-662.
64. Illangasekare M, Yarus M (1999) A tiny RNA that catalyzes both aminoacyltRNA and peptidyl-RNA synthesis. RNA 5: 1482-1489.
65. Illangasekare M, Yarus M (1999) Specific, rapid synthesis of Phe-RNA by RNA. Proceedings of the National Academy of Sciences 96: 5470-5475.
66. Jadhav VR, Yarus M (2002) Acyl-CoAs from coenzyme ribozymes. Biochemistry 41: 723-729.
67. Jayasena VK, Gold L (1997) In vitro selection of self-cleaving RNAs with a low pH optimum. Proceedings of the National Academy of Sciences 94: 10612- 10617.
68. Jenne A, Famulok M (1998) A novel ribozyme with ester transferase activity. Chemistry & Biology 5: 23-34.
69. Jeong S, Eom T-Y, Kim S-J, Lee S-W, Yu J (2001) In vitro selection of the RNA aptamer against the sialyl Lewis X and its inhibition of the cell adhesion. Biochemical and Biophysical Research Communications 281: 237-243.
70. Jones LA, Clancy LE, Rawlinson WD, White PA (2006) High-affinity aptamers to subtype 3a hepatitis C virus polymerase display genotypic specificity. Antimicrob Agents Chemother 50: 3019-3027.
71. Katahira M, Kobayashi S-i, Matsugami A, Ouhashi K, Uesugi S, et al. (1999) Structural study of an RNA aptamer for a Tat protein complexed with ligands. Nucleic Acids Symposium Series 42: 269-270.
72. Khvorova A, Kwak Y-G, Tamkun M, Majerfeld I, Yarus M (1999) RNAs that bind and change the permeability of phospholipid membranes. Proceedings of the National Academy of Sciences 96: 10649-10654.
73. Kikuchi K, Umehara T, Fukuda K, Kuno A, Hasegawa T, et al. (2005) A hepatitis C virus (HCV) internal ribosome entry site (IRES) domain III-IVtargeted aptamer inhibits translation by binding to an apical loop of domain IIId. Nucleic Acids Res 33: 683-692.
74. Ogawa A, Tomita N, Kikuchi N, Sando S, Aoyama Y (2004) Aptamer selection for the inhibition of cell adhesion with fibronectin as target. Bioorganic & Medicinal Chemistry Letters 14: 4001-4004.
75. Kim SJ, Kim MY, Lee JH, You JC, Jeong S (2002) Selection and stabilization of the RNA aptamers against the Human Immunodeficiency Virus Type-1 nucleocapsid protein. Biochemical and Biophysical Research Communications 291: 925-931.
76. Kimoto M, Shirouzu M, Mizutani S, Koide H, Kaziro Y, et al. (2002) Anti- (Raf-1) RNA aptamers that inhibit Ras-induced Raf-1 activation. European Journal of Biochemistry 269: 697-704.
77. Koizumi M, Breaker RR (2000) Molecular recognition of cAMP by an RNA aptamer. Biochemistry 39: 8983-8992.
78. Kumar PKR, Machida K, Urvil PT, Kakiuchi N, Vishnuvardhan D, et al. (1997) Isolation of RNA aptamers specific to the NS3 protein of hepatitis C virus from a pool of completely random RNA. Virology 237: 270-282.
79. Kumar RK, Yarus M (2001) RNA-catalyzed amino acid activation. Biochemistry 40: 6998-7004.
80. Lee SK, Park MW, Yang EG, Yu J, Jeong S (2005) An RNA aptamer that binds to the b-catenin interaction domain of TCF-1 protein. Biochemical and Biophysical Research Communications 327: 294-299.
81. Legiewicz M, Yarus M (2005) A more complex isoleucine aptamer with a cognate triplet. Journal of Biological Chemistry 280: 19815-19822.
82. Lorger M, Engstler M, Homann M, Göringer HU (2003) Targeting the variable surface of African trypanosomes with variant surface glycoproteinspecific, serum-stable RNA pptamers. Eukaryotic Cell 2: 84-94.
83. Lupold SE, Hicke BJ, Lin Y, Coffey DS (2002) Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen. Cancer Research 62: 4029-4033.
84. Mannironi C, Scerch C, Fruscoloni P, Tocchini-Valentini GP (2000) Molecular recognition of amino acids by RNA aptamers: The evolution into an L-tyrosine binder of a dopamine-binding RNA motif. RNA 6: 520-527.
85. Meli M, Vergne J, Maurel M-C (2003) In vitro selection of adenine-dependent hairpin ribozymes. Journal of Biological Chemistry 278: 9835-9842.
86. Missailidis S, Thomaidou D, Borbas KE, Price MR (2005) Selection of aptamers with high affinity and high specificity against C595, an anti-MUC1 IgG3 monoclonal antibody, for antibody targeting. Journal of Immunological Methods 296: 45-62.
87. Miyakawa S, Oguro A, Ohtsu T, Imataka H, Sonenberg N, et al. (2006) RNA aptamers to mammalian initiation factor 4G inhibit cap-dependent translation by blocking the formation of initiation factor complexes. RNA 12: 1825-1834.
88. Murphy MB, Fuller ST, Richardson PM, Doyle SA (2003) An improved method for the in vitro evolution of aptamers and applications in protein detection and purification. Nucleic Acids Research 31: e110.
89. Piganeau N, Thuillier V, Famulok M (2001) In vitro selection of allosteric ribozymes: Theory and experimental validation. Journal of Molecular Biology 312: 1177-1190.
90. Ryu Y, Kim K-J, Roessner CA, Scott AI (2006) Decarboxylative Claisen condensation catalyzed by in vitro selected ribozymes. Chemical Communications: 1439-1441.
91. Saito H, Kourouklis D, Suga H (2001) An in vitro evolved precursor tRNA with aminoacylation activity. The EMBO Journal 20: 1797-1878.
92. Schü rer H, Stembera K, Knoll D, Mayer G, Blind M, et al. (2001) Aptamers that bind to the antibiotic moenomycin A. Bioorganic & Medicinal Chemistry 9: 2557-2563.
93. Seelig B, Jäschke A (1999) A small catalytic RNA motif with Diels-Alderase activity. Chemistry & Biology 6: 167-176.
94. Seiwert SD, Stines Nahreini T, Aigner S, Ahn NG, Uhlenbeck OC (2000) RNA aptamers as pathway-specific MAP kinase inhibitors. Chemistry & Biology 7: 833-843.
95. Sengle G, Eisenfuhr A, Arora PS, Nowick JS, Famulok M (2001) Novel RNA catalysts for the Michael reaction. Chem Biol 8: 459-473.
96. Soukup GA, Emilsson GAM, Breaker RR (2000) Altering molecular recognition of RNA aptamers by allosteric selection. Journal of Molecular Biology 298: 623-632.
97. Sun L, Cui Z, Gottlieb RL, Zhang B (2002) A selected ribozyme catalyzing diverse dipeptide synthesis. Chem Biol 9: 619-628.
98. Tahiri-Alaoui A, Frigotto L, Manville N, Ibrahim J, Romby P, et al. (2002) High affinity nucleic acid aptamers for streptavidin incorporated into bi-specific capture ligands. Nucleic Acids Research 30: e45.
99. Tang J, Breaker RR (2000) Structural diversity of self-cleaving ribozymes. Proceedings of the National Academy of Sciences of the USA 97: 5784-5789.
100. Thomas M, Chédin S, Carles C, Riva M, Famulok M, et al. (1997) Selective targeting and inhibition of yeast RNA polymerase II by RNA aptamers. Journal of Biological Chemistry 272: 27980-27986.
101. Tok JB-H, Cho J, Rando RR (2000) RNA aptamers that specifically bind to a 16S ribosomal RNA decoding region construct. Nucleic Acids Research 28: 2902-2910.
102. Tuschl T, Sharp PA, Bartel DP (1998) Selection in vitro of novel ribozymes from a partially randomized U2 and U6 snRNA library. The EMBO Journal 17: 2637-2650.
103. Ulrich H, Ippolito JE, Pagán OR, Eterovic VA, Hann RM, et al. (1998) In vitro selection of RNA molecules that displace cocaine from the membrane bound nicotinic acetylcholine receptor. Proceedings of the National Academy of Sciences 95: 14051-14056.
104. Unrau PJ, Bartel DP (1998) RNA-catalysed nucleotide synthesis. Nature 395: 260-263.
105. Urvil PT, Kakiuchi N, Zhou D-M, Shimotohno K, Kumar PKR, et al. (1997) Selection of RNA aptamers that bind specifically to the NS3 protease of hepatitis C virus. European Journal of Biochemistry 248: 130-138.
106. Wallace ST, Schroeder R (1998) In vitro selection and characterization of streptomycin-binding RNAs: recognition discrimination between antibiotics. RNA 4: 112-123.
107. Wang Y, Killian J, Hamasaki K, Rando RR (1996) RNA molecules that specifically and stoichiometrically bind aminoglycoside antibiotics with high affinities. Biochemistry 35: 12338-12346.
108. Wecker M, Smith D, Gold L (1996) In vitro selection of a novel catalytic RNA: characterization of a sulfur alkylation reaction and interaction with small peptide. RNA 2: 982-994.
109. Weiss S, Proske D, Neumann M, Groschup MH, Kretzschmar HA, et al. (1997) RNA aptamers specifically interact with the prion protein PrP. Journal of Virology 71: 8790-8797.
110. Welch M, Majerfeld I, Yarus M (1997) 23S rRNA similarity from selection for peptidyl transferase mimicry. Biochemistry 36: 6614-6623.
111. White RR, Shan S, Rusconi CP, Shetty G, Dewhirst MW, et al. (2003) Inhibition of rat corneal angiogenesis by a nuclease-resistant RNA aptamer specific for angiopoietin-2. Proceedings of the National Academy of Sciences 100: 5028-5033.
112. Williams KP, Ciafre S, Tocchini-Valentini GP (1995) Selection of novel Mg2+ - dependent self-cleaving ribozymes. The EMBO Journal 14: 4551-4557.
113. Zhang B, Cech TR (1997) Peptide bond formation by in vitro selected ribozymes. Nature 390: 96-100.
114. Schuster P, Fontana W, Stadler PF, Hofacker IL (1994) From sequences to shapes and back: A case study in RNA secondary structures. Proceedings of the Royal Society of London B 255: 279-284.
115. Joyce GF (2004) Directed evolution of nucleic acid enzymes. Annual Review of Biochemistry 73: 791-836.
116. Geveretz J, Gan HH, Schlick T (2005) In vitro RNA random pools are not structurally diverse: A computational analysis. RNA 11: 853-863.
117. Meyers L, Lee J, Cowperthwaite M, Ellington A (2004) The robustness of naturally and artificially selected nucleic acid secondary structures. Journal of Molecular Evolution 58: 681-691.
118. Hayden EJ, Weikert C, Wagner A (2012) Directional selection causes decanalization in a Group I Ribozyme. PLOS ONE 7: e45351.
119. Wagner GP, Altenberg L (1996) Complex adaptations and evolution of evolvability. Evolution 50: 329-347.
120. Wagner A (2005) Robustness and Evolvability in Living Systems Princeton University Press.
121. Stich M, Manrubia SC (2011) Motif frequency and evolutionary search times in RNA populations. Journal of Theoretical Biology 280: 117-126.
122. Kun Á, Maurel M-C, Santos M, Szathmáry E (2005) Fitness landscapes, error thresholds, amd cofactors in aptamer evolution. In: Klussmann S, editor. The aptamer handbook. Weinheim: WILEY-VCH Verlag GmbH & Co. KGaA. pp. 54-92.
123. Maynard Smith J, Szathmáry E (1995) The Major Transition in Evolution. Oxford, UK: W.H. Freeman.
124. Czárán T, Szathmáry E (2000) Coexistence of replicators in prebiotic evolution. In: Dieckmann U, Law R, Metz JAJ, editors. The Geometry of Ecological Interactions. Cambridge: Cambridge University Press. pp. 116-134.
125. Könnyu B, Czárán T, Szathmáry E (2008) Prebiotic replicase evolution in a surface-bound metabolic system: parasites as a source of adaptive evolution. BMC Evolutionary Biology 8: 267.
126. Könnyu B, Czárán T (2011) The evolution of enzyme specificity in the metabolic replicator model of prebiotic evolution. PLOS ONE 6: e20931.
127. Szathmáry E, Demeter L (1987) Group selection of early replicators and the origin of life. Journal of Theoretical Biology 128.
128. Hubai AG (2013) Emergence and evolution of primeval metabolic systems. Budapest: Eötvös Loránd University (Supervisor Á . Kun).
129. Szabó P, Scheuring I, Czárán T, Szathmáry E (2002) In silico simulations reveal that replicators with limited dispersal evolve towards higher efficiency and fidelity. Nature 420: 340-343.
130. Jones BL, Enns RH, Rangnekar SS (1976) On the theory of selection of coupled macromolecular systems. Bulletin of Mathematical Biology 38: 15-28.
131. Thompson CJ, McBride JL (1974) On Eigen's theory of the self-organization of matter and the evolution of biological macromolecules. Mathematical biosciences 21: 127-142.
132. Schuster P, Swetina J (1988) Stationary mutant distributions and evolutionary optimization. Bulletin of Mathematical Biology 50: 635-660.
133. Hernandez V, Roman JE, Vidal V (2005) SLEPc: A scalable and flexible toolkit for the solution of eigenvalue problems. ACM Trans Math Softw 31: 351-362.
134. Balay S, Buschelman K, Eijkhout V, Gropp WD, Kaushik D, et al. (2008) PETSc Users Manual. Illinois, USA: Argonne National Laboratory.
135. Fontana W, Könings DAM, Stadler PF, Schuster P (1993) Statictics of RNA secondary structures. Biopolymers 33: 1389-1404.